𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Transforming growth factor β1, urokinase-type plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in head and neck squamous carcinoma and normal adjacent mucosa

✍ Scribed by Fatima S. Pasini; M. Mitzi Brentani; Luiz P. Kowalski; Miriam H. H. Federico


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
305 KB
Volume
23
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis


Background:

A balance between urokinase-type plasminogen activator (upa) and its main inhibitor type-1 (pai-1) appears to be important for cancer invasive behavior. since upa/pai-1 system seems to be regulated by transforming growth factor beta1 (tgfbeta1) in different cell types, our aim was to investigate the relationship between the expression of the three genes and lymph node status in head and neck squamous cell carcinomas (hnscc) at specific sites.

Materials and methods:

Upa, pai-1, and tgfbeta1 mrnas were determined by northern analysis in tumor, and paired normal mucosa samples were obtained from 91 operable hnscc patients.

Results:

In oral cavity, excluding tongue, tgfbeta1, pai-1, and upa mrnas values were consistently lower in the normal tissues than in tumors. in larynx tumors, tgfbeta1 expression was increased, but no statistically significant differences were found for upa or pai-1 mrnas as compared with normal tissues. tongue tumors overexpressed only upa mrna, and upa levels showed significant parallel variations with tgfbeta1 and pai-1 mrnas mainly in pn+ tumors. in oral cavity tumors, an inverse correlation between tgfbeta1 and upa was observed in pn0 subgroup, elevated upa mrna was counterbalanced by high pai-1 mrna tgfbeta1, and pai-1 were not coordinately expressed. correlations between the three markers were not found in larynx. hypopharynx tumors, all staged as pn+, expressed the lowest tgfbeta1 mrna mean values.

Conclusions:

Combined information about tgfbeta1, upa, and pai-1 mrnas may add some clues to the understanding of the pathophysiological role of upa system in head and neck squamous cell carcinoma.


📜 SIMILAR VOLUMES


Prognostic value of plasminogen activato
✍ Luciënne Speleman; Jeroen D. F. Kerrebijn; Maxime P. Look; Cees A. Meeuwis; John 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB 👁 1 views

## Abstract ## Background. Tumor cell biological factors, such as urokinase plasminogen activator (uPA) and its inhibitor plasminogen activator inhibitor‐1 (PAI‐1), cathepsin D, and c‐myc play a role in tumor invasion, metastasis, and proliferation. In this study, the prognostic importance of thes

Growth state-dependent regulation of pla
✍ Jeffrey R. Boehm; Stacie M. Kutz; E. Helene Sage; Lisa Staiano-Coico; Paul J. Hi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 412 KB 👁 1 views

Transit of serumstimulated normal rat kidney (NRK) epthelial cells through the first division cycle after release from quiescence (G 0 ) provided a model system to assess the kinetics and mechanisms underlying PAI-1 expression in a growth "activated" phenotype. PAI-1 mRNA transcripts increased by mo

Transforming growth factor β-1 and amphi
✍ Corinne Giusti; Sylvie Desruisseau; Lin Ma; Fabien Calvo; Pierre-Marie Martin; Y 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 276 KB

## Abstract Amphireguline (AR) is an epidermal growth factor (EGF)‐related peptide that seems to play an important role in breast cancer progression. We have demonstrated recently that suppression of AR expression in transformed breast epithelial cells considerably reduced both size and neovascular

Effects of pharmacologic antagonists of
✍ Caren C. Bancroft; Zhong Chen; Jason Yeh; John B. Sunwoo; Ning T. Yeh; Sadhana J 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 296 KB 👁 1 views

## Abstract We previously reported that expression of angiogenesis factors interleukin‐8 (IL‐8) and vascular endothelial growth factor (VEGF) is promoted by coactivation of transcription factors nuclear factor‐kappaB (NF‐κB) and activator protein‐1 (AP‐1) by interleukin‐1α in human head and neck sq